Active, Not RecruitingEarly Phase 1ketamine

Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology

Sponsored by CAMC Health System

NCT ID
NCT07040163
Target Enrollment
276 participants
Start Date
2025-03-07
Est. Completion
2026-06

About This Study

This study aims to reduce pain during interventional radiology (IR) procedures, making the experience better for patients. Typically, doctors use medications like fentanyl and midazolam for sedation. This research will focus on patients undergoing biopsies and drainage procedures, often associated with significant discomfort. Patients will be randomly assigned to receive either fentanyl/midazolam or ketamine/midazolam combinations for sedation. A coordinator will collect information on pain levels and satisfaction, as well as monitor any extra medications needed and side effects. The investigators hope to find that ketamine helps decrease pain and improves satisfaction compared to fentanyl, without increasing complications.

Conditions Studied

SedationInterventional RadiologyBiopsyDrainage Procedure

Interventions

  • ketamine
  • fentanyl
  • Midazolam

Eligibility

Age:18 Years - 90 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Planned to undergo image-guided bone biopsy, lung biopsy, or percutaneous drainage
* Eligible to receive ketamine or fentanyl sedation
* Any sex/gender, any race
* Aged 18-89

Exclusion Criteria:

* Pregnant/lactating
* Incarceration
* Currently taking an opioid agonist/antagonist
* Food consumed in past 6-8 hours
* Allergies to drugs used in the study
* Lacks mental capacity for reporting pain scores
* Hypotension or respiratory failure precluding fentanyl sedation
* Uncontrolled hypertension precluding ketamine sedation
* Condition for which hypertension would be a concern
* Schizophrenia

Study Locations (1)

CAMC Memorial
Charleston, West Virginia, United States

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source